מלטה - אנגלית - Medicines Authority

merz pharmaceuticals gmbh eckenheimer landstrasse 100, d-60318 frankfurt am main, germany - amantadine sulfate - solution for infusion - amantadine sulfate 0.4 mg/ml - anti-parkinson drugs

הודו - אנגלית - Central Drugs Standard Control Organization

synapse - trifluoperazine hcl.,chlorpromazine hcl.,trihexyphenidyl hcl. - f. tab - 5,50,2;mg - 10

הודו - אנגלית - Central Drugs Standard Control Organization

synapse - trihexyphenidyl hcl. - tab - 2 mg - 10

הודו - אנגלית - Central Drugs Standard Control Organization

synapse - trifluoperazine hcl.,trihexyphenidyl hcl. - tab - 5,2;mg - 10

בנגלדש - אנגלית - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - procyclidine hydrochloride - tablet - 5 mg

בנגלדש - אנגלית - DGDA (Directorate General of Drug Administration)

popular pharmaceuticals ltd. - procyclidine hydrochloride - injection - 10 mg/2 ml

קניה - אנגלית - Pharmacy and Poisons Board

galaxy pharmaceutical ltd p.o. box 39107-00623, nairobi - benzhexol or trihexyphenidyl bp - tablet - 5mg - trihexyphenidyl

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

krka d.d. - rasagiline - tablets - 1mg - anti-parkinson drugs, monoamine oxidase b inhibitors - rasagiline krka is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

rowex ltd - rasagiline - tablet - 1 milligram(s) - monoamine oxidase b inhibitors; rasagiline - anti-parkinson drugs, monoamine oxidase b inhibitors - rasagiline rowex is indicated for the treatment of idiopathic parkinson’s disease (pd) as monotherapy (without levodopa) or as adjunct therapy (with levodopa) in patients with end of dose fluctuations

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

ucb australia pty ltd t/a ucb pharma division of ucb australia - rotigotine, quantity: 18 mg - drug delivery system, transdermal - excipient ingredients: povidone; ascorbyl palmitate; dl-alpha-tocopherol; sodium metabisulfite; methylated trimethylated silica; heptane - parkinson's disease: neupro is indicated as monotherapy, or in combination with levodopa, for the treatment of idiopathic parkinson's disease from early stage to advanced disease. restless legs syndrome: neupro is indicated for the symptomatic treatment of moderate to severe idiopathic restless legs syndrome in adults.